Table 10.
Clinical trials for stem cells.
| Clinical trial # | Clinical trial title | Intervention | Characteristics | |||
|---|---|---|---|---|---|---|
| Enrollment | Model | Allocation | Phase | |||
| NCT02104713 | Stem cell therapy to improve burn wound healing | Biological: Allogeneic (MSC's) Application to the Burn Wounds | 20 | SGA | – | 1 |
| NCT03113747 | Allogeneic ADSCs and platelet-poor plasma fibrin hydrogel to treat the patients with burn wounds (ADSCs-BWs) (ADSCs-BWs) | Biological: ALLO-ASCs | 20 | PA | R | 1, 2 |
| NCT02394873 | A study to evaluate the safety of ALLO-ASC-DFU in the subjects with deep second-degree burn wound | Biological: ALLO-ASC-DFU | 5 | SGA | – | 1 |
| NCT02619851 | A clinical trial to evaluate the safety and efficacy of ALLO-ASC-DFU for second deep degree burn injury subjects | Biological: ALLO-ASC-DFU Device: Conventional Therapy |
22 | PA | R | 2 |
| NCT03183622 | A follow-up study to evaluate the safety of ALLO-ASC-DFU in ALLO-ASC-BI-101 clinical trial | Biological: ALLO-ASC-DFU | 5 | Ob | Case | 1 |
| NCT02779205 | Child's adipose cells: capacity of tissue regeneration (cicASChild) | Procedure: Adipose tissue sample | 38 | PA | NR | – |
–, study did not mention; ASC, Adipose-derived Stem Cells; MSC, Mesenchymal Stem Cells; STSG, Split-Thickness Skin Graft. Model: Ob, Observational; PA, Parallel Assignment (Therapy vs. SOC); SGA, Single Group Assignment. Allocation: R, Randomized; NR, Non-Randomized.